Edition:
India

Morepen Laboratories Ltd (MORL.NS)

MORL.NS on National Stock Exchange of India

20.90INR
3:51pm IST
Change (% chg)

Rs-0.05 (-0.24%)
Prev Close
Rs20.95
Open
Rs21.15
Day's High
Rs21.45
Day's Low
Rs20.65
Volume
1,684,796
Avg. Vol
1,120,691
52-wk High
Rs24.50
52-wk Low
Rs14.70

Chart for

About

Morepen Laboratories Limited is a pharmaceutical company. The Company's divisions include Active Pharmaceutical Ingredients (API), Home Diagnostics and Finished Formulations. The API division offers products, such as Loratadine Process-1, Desloratadine, Atorvastatin Calcium Amorphous, Atorvastatin Calcium Crystalline Form VI and... (more)

Overall

Beta: 0.54
Market Cap(Mil.): Rs7,781.99
Shares Outstanding(Mil.): 449.83
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.15 16.44
EPS (TTM): -- -- --
ROI: -- 14.99 10.62
ROE: -- 16.33 14.20

BRIEF-India's Morepen Labs Sept-qtr profit rises

* Sept quarter net profit 103.8 million rupees versus 83.4 million rupees year ago

10 Nov 2017

BRIEF-India's Morepen Labs ties up with Vesale Pharma International

* Vesale Pharma may invest in future for setting up worldwide manufacturing and research and development facility in India with co Source text - http://bit.ly/2yk7GTz Further company coverage:

09 Nov 2017

BRIEF-India's Morepen Laboratories June-qtr profit falls

* June quarter net profit 19.6 million rupees versus profit 29.8 million rupees year ago

11 Sep 2017

Earnings vs. Estimates